Tumor FLT uptake was significantly reduced in the Pan-HER group (p ≤ 0.01) while it was significantly increased in the groups treated with vehicle (p ≤ 0.01) and anti-HER2 (p ≤ 0.01) (Table 2). Here, ERBB2 is linked to neoplasm.